Charles Schoch, See Remarks at Candel Therapeutics, Inc. (CADL), sold 5,000 shares at $8.83 ($44K) on 2025-03-17, disclosed to the SEC on 2025-03-19.
Scheduled sale ($44k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CADL | SELL | 2024-07-19 | $128K | — | Filing → |
| CADL | SELL | 2024-07-15 | $106K | — | Filing → |